155 related articles for article (PubMed ID: 35578283)
1. ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysis.
Xiao Y; Deng Z; Li Y; Wei B; Chen X; Zhao Z; Xiu Y; Hu M; Alahdal M; Deng Z; Wang D; Liu J; Li W
Cancer Cell Int; 2022 May; 22(1):193. PubMed ID: 35578283
[TBL] [Abstract][Full Text] [Related]
2. UBE2T is a prognostic biomarker and correlated with Th2 cell infiltrates in retinoblastoma.
Wang Z; Chen N; Liu C; Cao G; Ji Y; Yang W; Jiang Q
Biochem Biophys Res Commun; 2022 Jul; 614():138-144. PubMed ID: 35594577
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of
Zou R; Xu H; Li F; Wang S; Zhu L
DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
[TBL] [Abstract][Full Text] [Related]
4. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.
Wang Z; Hu S; Li X; Liu Z; Han D; Wang Y; Wei L; Zhang G; Wang X
BMC Cancer; 2021 Nov; 21(1):1188. PubMed ID: 34743685
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity.
Zhang X; Li L; Huang S; Liao W; Li J; Huang Z; Huang Y; Lian Y
Oxid Med Cell Longev; 2022; 2022():5322929. PubMed ID: 35340220
[TBL] [Abstract][Full Text] [Related]
6. Identification of the prognostic value of Th1/Th2 ratio and a novel prognostic signature in basal-like breast cancer.
Xiao Y; Huang Y; Jiang J; Chen Y; Wei C
Hereditas; 2023 Jan; 160(1):2. PubMed ID: 36694223
[TBL] [Abstract][Full Text] [Related]
7. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
[TBL] [Abstract][Full Text] [Related]
8. Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma.
Deng Y; Chen X; Huang C; Song J; Feng S; Chen X; Zhou R
J Oncol; 2022; 2022():3794021. PubMed ID: 35444699
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients.
Wang Z; Chen J; Zhong MZ; Huang J; Hu YP; Feng DY; Zhou ZJ; Luo X; Liu ZQ; Jiang WZ; Zhou WB
Cancer Chemother Pharmacol; 2017 Mar; 79(3):535-543. PubMed ID: 28243684
[TBL] [Abstract][Full Text] [Related]
10.
Xia L; Su X; Shen J; Meng Q; Yan J; Zhang C; Chen Y; Wang H; Xu M
Cancer Manag Res; 2018; 10():663-670. PubMed ID: 29670400
[TBL] [Abstract][Full Text] [Related]
11. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
Tang D; Zhao X; Zhang L; Wang Z; Wang C
J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
[TBL] [Abstract][Full Text] [Related]
12. Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer.
Zhu X; Li T; Niu X; Chen L; Ge C
Oncol Lett; 2020 Oct; 20(4):44. PubMed ID: 32802166
[TBL] [Abstract][Full Text] [Related]
13. Genetic interactions between ANLN and KDR are prognostic for breast cancer survival.
Dai X; Chen X; Hakizimana O; Mei Y
Oncol Rep; 2019 Dec; 42(6):2255-2266. PubMed ID: 31578580
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers.
Cui Z; Mo J; Song P; Wang L; Wang R; Cheng F; Wang L; Zou F; Guan X; Zheng N; Yang X; Wang W
Front Genet; 2022; 13():1000339. PubMed ID: 36199577
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.
Zeng S; Yu X; Ma C; Song R; Zhang Z; Zi X; Chen X; Wang Y; Yu Y; Zhao J; Wei R; Sun Y; Xu C
Sci Rep; 2017 Jun; 7(1):3151. PubMed ID: 28600503
[TBL] [Abstract][Full Text] [Related]
16. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma.
Wang X; Liu Y; Leng X; Cao K; Sun W; Zhu J; Ma J
Pathol Oncol Res; 2021; 27():632531. PubMed ID: 34257599
[No Abstract] [Full Text] [Related]
17. ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.
Dai X; Mei Y; Chen X; Cai D
Front Genet; 2019; 10():790. PubMed ID: 31636652
[No Abstract] [Full Text] [Related]
18. Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker.
Liu K; Cui L; Li C; Tang C; Niu Y; Hao J; Bu Y; Chen B
Front Genet; 2022; 13():922472. PubMed ID: 35991576
[TBL] [Abstract][Full Text] [Related]
19. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
20. Prognostic significance of ANLN in lung adenocarcinoma.
Long X; Zhou W; Wang Y; Liu S
Oncol Lett; 2018 Aug; 16(2):1835-1840. PubMed ID: 30008873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
